Tetanus
📧 Sign up to get email alerts when something new happens for Tetanus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines [Phase 4]
Phase 4 clinical trial assessing immunogenicity and safety of PENTAXIM vaccine in the Philippines for diphtheria, tetanus, poliomyelitis, pe…
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Immunogenicity and Safety of Pentaxim™ in an Indian Population [Phase 3]
Phase 3 trial evaluated immunogenicity and safety of Pentaxim in an Indian population. The study has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV [Phase 3]
Phase 3 trial comparing the immunogenicity and safety of Tetraxim versus local DTP + IPV has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand [Phase 4]
Phase 4 trial assessing immunogenicity and safety of the Sanofi Pasteur Pentaxim combined vaccine in infants in Thailand; the study has comp…
-
CLINICAL_TRIALS trial_result · 2012-01-31Clinical Trial Update: Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine [Phase 3]
Phase 3 trial evaluating safety, immunogenicity, and lot-to-lot comparability of the DTaP vaccine DAPTACEL when administered with other reco…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants [Phase 3]
This Phase 3 trial compares ACTACEL (DTaP-PRP-T) with separate DTaP and Act-HIB vaccines in healthy infants and has completed.
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine
A clinical trial update reports antibody persistence in healthy children after primary and booster vaccination with DTaP-IPV-Hep B-PRP-T com…
-
CLINICAL_TRIALS trial_result · 2011-11-07Clinical Trial Update: Pentavalent DTaP-Hep B-IPV [Phase 2]
Phase 2 trial of the pentavalent DTaP-Hep B-IPV vaccine has completed, evaluating protection against diphtheria, hepatitis B, poliomyelitis,…
-
CLINICAL_TRIALS trial_result · 2011-10-05Clinical Trial Update: Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age [Phase 4]
Phase 4 study assessing immunogenicity and safety of a TETRAXIM booster given to children aged 4-6 years.
-
CLINICAL_TRIALS trial_result · 2011-09-22Clinical Trial Update: Immunology of Non-specific Effects of Vaccine [Phase 4]
Phase 4 clinical trial evaluating non-specific immunological effects of vaccines has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-15Clinical Trial Update: Pneumonia in Tetanus Study [NA]
The pneumonia-in-tetanus clinical trial sponsored by the Oxford University Clinical Research Unit in Vietnam has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-23Clinical Trial Update: Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL® [Phase 2]
A Phase 2 trial evaluated concomitant administration of Menactra with a fifth dose of DAPTACEL in children aged 4 to 6 years. The study has …
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: The Change of the Tetanus Antibody Titer After Single Injection of Td and Simultaneous Injection of TIG With Td
This trial updates how tetanus antibody titers change after a single Td vaccination and when Td is given together with tetanus immune globul…
-
CLINICAL_TRIALS trial_result · 2011-04-07Clinical Trial Update: Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine [Phase 4]
Phase 4 post-marketing evaluation of adverse reactions following receipt of the recommended adolescent pertussis vaccine; sponsor is Sanofi …
-
CLINICAL_TRIALS trial_result · 2011-03-29Clinical Trial Update: A Study to Assess the Safety of Adacel® Vaccine [Phase 3]
Phase 3 safety study of Adacel vaccine completed; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-02-18Clinical Trial Update: Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td [Phase 4]
Phase 4 trial evaluating Canadian-manufactured tetanus and diphtheria toxoids adsorbed vaccine versus U.S.-manufactured Td; results posted i…
-
CLINICAL_TRIALS trial_result · 2011-02-10Clinical Trial Update: Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years [Phase 3]
Phase 3 trial updating immunogenicity and safety of Kinrix+ (MMR) with and without Varicella in healthy children 4-6 years; completed with r…
-
CLINICAL_TRIALS trial_result · 2010-12-24Clinical Trial Update: Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults [Phase 3]
A Phase 3 booster study of a combined Diphtheria-tetanus-acellular Pertussis vaccine in healthy adults has completed.
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine [Phase 3]
Phase 3 trial update of reduced-antigen-content acellular pertussis vaccine and diphtheria-tetanus-acellular pertussis vaccine. The study ha…
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age [Phase 3]
A Phase 3 study comparing safety and immunogenicity of the Tdap vaccine to the DTaP vaccine in children aged 4 to 6 years, with results post…
-
CLINICAL_TRIALS trial_result · 2010-10-21Clinical Trial Update: Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX® [Phase 4]
Phase 4 post-licensure study assessing safety and immunogenicity of ADACEL and BOOSTRIX vaccines across multiple centers.
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9 [Phase 3]
Phase 3 trial update assessing persistence of Tdap vaccine (Boostrix) over 1, 3, 5, and 9 years after initial dose and immunogenicity/safety…
-
CLINICAL_TRIALS trial_result · 2010-08-05Clinical Trial Update: Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine. [Phase 3]
Phase 3 trial evaluating Boostrix vaccine versus Decavac for tetanus and acellular pertussis; completed with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-07-22Clinical Trial Update: Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine [Phase 4]
Phase 4 open-label multicenter trial assessing safety of redosing with the ADACEL vaccine. Results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-06-07Clinical Trial Update: An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster [Phase 4]
Phase 4 trial evaluating the immunogenicity and safety of a tetanus, diphtheria and acellular pertussis vaccine booster.